Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line

被引:4
|
作者
Sen, Kamalika [1 ]
Sarkar, Arijita [1 ]
Maji, Ranjan Kumar [1 ]
Ghosh, Zhumur [1 ]
Gupta, Sanjib [1 ]
Ghosh, Tapash Chandra [1 ]
机构
[1] Bose Inst, Bioinformat Ctr, P 1-12,CIT Scheme 7 M, Kolkata 700054, India
关键词
CHRONIC MYELOID-LEUKEMIA; GENE-EXPRESSION; KINASE-ACTIVITY; MESSENGER-RNA; CIRCULAR RNAS; MICRORNA; PROTEIN; NETWORK; DATABASE; CLATHRIN;
D O I
10.1039/c6mb00568c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by increased proliferation or abnormal accumulation of granulocytic cell line without the depletion of their capacity to differentiate. A reciprocal chromosomal translocation proceeding to the `Philadelphia chromosome', involving the ABL proto-oncogene and BCR gene residing on Chromosome 9 and 22 respectively, is observed to be attributed to CML pathogenesis. Recent studies have been unraveling the crucial role of genomic `dark matter' or the non-coding repertoire in cancer initiation and progression. The intricate cross-talk between competitive endogenous RNAs (ceRNAs) provides a scaffold to systematically functionalize the miRNA response element harboring non-coding RNAs and incorporate them with the protein-coding RNA dimension in complex ceRNA networks. This network of coding and non-coding transcriptome linked by shared miRNAs evidently offers a platform to elucidate the complex regulatory interactions at the post-transcriptional level in human cancers. In this context, analyzing CML, from the perspective of the ceRNA hypothesis, surely craves intensive attention and a comprehensive discussion. Here, we performed RNA-seq data analysis to retrieve Lymphoblastoid and CML coding as well as non-coding repertoire and constructed a ceRNA network for the CML cell line, considering the non-cancer lymphoblastoid cell line as the control. We investigated if any alteration exists in the ceRNA landscape of the transcripts which are exhibiting differential expression across the two cell lines and observed that the major ceRNA regulators vary in cancer network when compared with the Lymphoblastoid network. The top ranked significant functional modules in the ceRNA network display cancer associated attributes and reveal putative regulators in CML pathogenesis.
引用
收藏
页码:3633 / 3642
页数:10
相关论文
共 50 条
  • [21] Muscarinic receptor mediated cAMP response in human K562 chronic myelogenous leukemia cells
    Cabadak, Hulya
    Aydin, Banu
    Kan, Beki
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2011, 36 (03): : 188 - 192
  • [22] Reversal of the resistance to ST1571 in human chronic myelogenous leukemia K562 cells
    Mukai, M
    Che, XF
    Furukawa, T
    Sumizawa, T
    Aoki, S
    Ren, XQ
    Haraguchi, M
    Sugimoto, Y
    Kobayashi, M
    Takamatsu, H
    Akiyama, S
    CANCER SCIENCE, 2003, 94 (06) : 557 - 563
  • [23] Puerarin leads to K562 cell apoptosis of chronic myelogenous leukemia via induction of autophagy
    Gao, Da
    Xiao, Zhen
    Li, Hui-ping
    JOURNAL OF BUON, 2017, 22 (06): : 1554 - 1562
  • [24] Induction of megakaryocytic differentiation in chronic myelogenous leukemia cell K562 by 3-hydrogenkwadaphnin
    Meshkini, Azadeh
    Yazdanparast, Razieh
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 40 (06): : 944 - 951
  • [25] Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562
    Hiroko Isoda
    Tadaatsu Nakahara
    Cytotechnology, 1997, 25 : 191 - 195
  • [26] Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562
    Isoda, H
    Nakahara, T
    CYTOTECHNOLOGY, 1997, 25 (1-3) : 191 - 195
  • [27] Mass Spectrometric Analysis of Affinity-Purified Proteasomes from the Human Myelogenous Leukemia K562 Cell Line
    Artamonova, T. O.
    Khodorkovskii, M. A.
    Tsimokha, A. S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2014, 40 (06) : 666 - 680
  • [28] Mass spectrometric analysis of affinity-purified proteasomes from the human myelogenous leukemia K562 cell line
    T. O. Artamonova
    M. A. Khodorkovskii
    A. S. Tsimokha
    Russian Journal of Bioorganic Chemistry, 2014, 40 : 666 - 680
  • [29] K-562 - A PLURIPOTENTIAL CELL-LINE OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    LOZZIO, CB
    LOZZIO, BB
    BAMBERGER, EG
    FELIU, AS
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 754 - 754
  • [30] Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate
    Wang, X. J.
    Li, Y. H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 6413 - 6418